DrugInteractions:CYP2C9inhibitorDrugInteractions:InteractionwithgrapefruitDosageForm andStrengths:Nasal sprayDrugInteractions:CYP2D6inhibitorAdverseReactions:May causenauseaDrugInteractions:CYP2D6substrateDosageForm andStrengths:TopicalproductPatientCounselingInformation:Advises use ofcontraceptionPatientCounselingInformation:Advises limitingsun exposureUse in SpecificPopulations:Renalimpairmentuse describedDosage andAdministration:Dose adjustmentrequired forhepaticimpairmentContraindications,Warnings, andPrecautions: Riskof bleedingContraindications,Warnings, andPrecautions: Riskof respiratorydepressionUse in SpecificPopulations:Hepaticimpairmentuse describedPatientCounselingInformation:Advises avoidingalcoholconsumptionContraindications,Warnings, andPrecautions: Riskof serotoninsyndromeContraindications,Warnings, andPrecautions: Riskof nephrotoxicityDosage andAdministration:Doseadjustmentrequired forrenal impairmentUse in SpecificPopulations: Hasreproductivetoxicity/teratogenicitywarningUse inSpecificPopulations:Pediatric usedescribedAdverseReactions:May causeweight gainAdverseReactions:May causeweight lossContraindications,Warnings, andPrecautions: Riskof QT prolongationDosage Formand Strengths:Extended-releaseformulationDrug AbuseandDependence:Risk for Abuse,MisuseAdverseReactions:10+ AdverseReactionslistedDosage andAdministration:Twice-dailydosingDosageForm andStrengths:TransdermalpatchDosageForm andStrengths:InhaledmedicationIndications andUsage: Hasmultiple FDA-approvedindications foruseDrug AbuseandDependence:ControlledSubstance(Schedule II-V)DosageForm andStrengths:Oral capsuleDrug AbuseandDependence:Risk forDependenceHowSupplied/Storageand Handling:RefrigerationrequiredDosage andAdministration:Once-dailydosingDrugInteractions:CYP2C9substrateIndicationsandUsage:ADHDDosageForm andStrengths:Oral solutionContraindications,Warnings, andPrecautions: Riskof hypoglycemiaAdverse Reactions:May causedrowsiness/sedationPatient CounselingInformation:Advises againstdriving oroperating heavymachineryIndicationsandUsage:PainIndicationsand Usage:HypertensionDosageForm andStrengths:VaginalproductIndicationsandUsage:DiabetesContraindications,Warnings, andPrecautions: Riskof hepatotoxicityDrugInteractions:InteractionwithamiodaroneDrugInteractions:CYP3A4inducerDrugInteractions:Interactionwith warfarinIndications andUsage:Asthma/COPDContraindications,Warnings, andPrecautions: BlackBox WarningIndicationsand Usage:Anti-infectivePatientCounselingInformation:Containsmissed doseinstructionsDrugInteractions:CYP3A4inhibitorHowSupplied/Storageand Handling:Store at roomtemperatureUse in SpecificPopulations:NotrecommendedduringpregnancyAdverseReactions:May causeheadacheDosageForm andStrengths:Oral tabletDrugInteractions:CYP3A4substrateDosage andAdministration:Weekly dosingDosageForm andStrengths:RectalproductIndicationsand Usage:DepressionContraindications,Warnings, andPrecautions: Riskof C. difficileinfectionDosageForm andStrengths:InjectablemedicationContraindications,Warnings, andPrecautions: Riskof severe rashDosageForm andStrengths:OphthalmicproductUse inSpecificPopulations:Geriatric usedescribedHowSupplied/Storageand Handling:Protect from lightUse in SpecificPopulations:Notrecommendedduring lactationDrugInteractions:CYP2C9inhibitorDrugInteractions:InteractionwithgrapefruitDosageForm andStrengths:Nasal sprayDrugInteractions:CYP2D6inhibitorAdverseReactions:May causenauseaDrugInteractions:CYP2D6substrateDosageForm andStrengths:TopicalproductPatientCounselingInformation:Advises use ofcontraceptionPatientCounselingInformation:Advises limitingsun exposureUse in SpecificPopulations:Renalimpairmentuse describedDosage andAdministration:Dose adjustmentrequired forhepaticimpairmentContraindications,Warnings, andPrecautions: Riskof bleedingContraindications,Warnings, andPrecautions: Riskof respiratorydepressionUse in SpecificPopulations:Hepaticimpairmentuse describedPatientCounselingInformation:Advises avoidingalcoholconsumptionContraindications,Warnings, andPrecautions: Riskof serotoninsyndromeContraindications,Warnings, andPrecautions: Riskof nephrotoxicityDosage andAdministration:Doseadjustmentrequired forrenal impairmentUse in SpecificPopulations: Hasreproductivetoxicity/teratogenicitywarningUse inSpecificPopulations:Pediatric usedescribedAdverseReactions:May causeweight gainAdverseReactions:May causeweight lossContraindications,Warnings, andPrecautions: Riskof QT prolongationDosage Formand Strengths:Extended-releaseformulationDrug AbuseandDependence:Risk for Abuse,MisuseAdverseReactions:10+ AdverseReactionslistedDosage andAdministration:Twice-dailydosingDosageForm andStrengths:TransdermalpatchDosageForm andStrengths:InhaledmedicationIndications andUsage: Hasmultiple FDA-approvedindications foruseDrug AbuseandDependence:ControlledSubstance(Schedule II-V)DosageForm andStrengths:Oral capsuleDrug AbuseandDependence:Risk forDependenceHowSupplied/Storageand Handling:RefrigerationrequiredDosage andAdministration:Once-dailydosingDrugInteractions:CYP2C9substrateIndicationsandUsage:ADHDDosageForm andStrengths:Oral solutionContraindications,Warnings, andPrecautions: Riskof hypoglycemiaAdverse Reactions:May causedrowsiness/sedationPatient CounselingInformation:Advises againstdriving oroperating heavymachineryIndicationsandUsage:PainIndicationsand Usage:HypertensionDosageForm andStrengths:VaginalproductIndicationsandUsage:DiabetesContraindications,Warnings, andPrecautions: Riskof hepatotoxicityDrugInteractions:InteractionwithamiodaroneDrugInteractions:CYP3A4inducerDrugInteractions:Interactionwith warfarinIndications andUsage:Asthma/COPDContraindications,Warnings, andPrecautions: BlackBox WarningIndicationsand Usage:Anti-infectivePatientCounselingInformation:Containsmissed doseinstructionsDrugInteractions:CYP3A4inhibitorHowSupplied/Storageand Handling:Store at roomtemperatureUse in SpecificPopulations:NotrecommendedduringpregnancyAdverseReactions:May causeheadacheDosageForm andStrengths:Oral tabletDrugInteractions:CYP3A4substrateDosage andAdministration:Weekly dosingDosageForm andStrengths:RectalproductIndicationsand Usage:DepressionContraindications,Warnings, andPrecautions: Riskof C. difficileinfectionDosageForm andStrengths:InjectablemedicationContraindications,Warnings, andPrecautions: Riskof severe rashDosageForm andStrengths:OphthalmicproductUse inSpecificPopulations:Geriatric usedescribedHowSupplied/Storageand Handling:Protect from lightUse in SpecificPopulations:Notrecommendedduring lactation

BINGO Rx - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
  1. Drug Interactions: CYP2C9 inhibitor
  2. Drug Interactions: Interaction with grapefruit
  3. Dosage Form and Strengths: Nasal spray
  4. Drug Interactions: CYP2D6 inhibitor
  5. Adverse Reactions: May cause nausea
  6. Drug Interactions: CYP2D6 substrate
  7. Dosage Form and Strengths: Topical product
  8. Patient Counseling Information: Advises use of contraception
  9. Patient Counseling Information: Advises limiting sun exposure
  10. Use in Specific Populations: Renal impairment use described
  11. Dosage and Administration: Dose adjustment required for hepatic impairment
  12. Contraindications, Warnings, and Precautions: Risk of bleeding
  13. Contraindications, Warnings, and Precautions: Risk of respiratory depression
  14. Use in Specific Populations: Hepatic impairment use described
  15. Patient Counseling Information: Advises avoiding alcohol consumption
  16. Contraindications, Warnings, and Precautions: Risk of serotonin syndrome
  17. Contraindications, Warnings, and Precautions: Risk of nephrotoxicity
  18. Dosage and Administration: Dose adjustment required for renal impairment
  19. Use in Specific Populations: Has reproductive toxicity/teratogenicity warning
  20. Use in Specific Populations: Pediatric use described
  21. Adverse Reactions: May cause weight gain
  22. Adverse Reactions: May cause weight loss
  23. Contraindications, Warnings, and Precautions: Risk of QT prolongation
  24. Dosage Form and Strengths: Extended-release formulation
  25. Drug Abuse and Dependence: Risk for Abuse, Misuse
  26. Adverse Reactions: 10+ Adverse Reactions listed
  27. Dosage and Administration: Twice-daily dosing
  28. Dosage Form and Strengths: Transdermal patch
  29. Dosage Form and Strengths: Inhaled medication
  30. Indications and Usage: Has multiple FDA-approved indications for use
  31. Drug Abuse and Dependence: Controlled Substance (Schedule II-V)
  32. Dosage Form and Strengths: Oral capsule
  33. Drug Abuse and Dependence: Risk for Dependence
  34. How Supplied/Storage and Handling: Refrigeration required
  35. Dosage and Administration: Once-daily dosing
  36. Drug Interactions: CYP2C9 substrate
  37. Indications and Usage: ADHD
  38. Dosage Form and Strengths: Oral solution
  39. Contraindications, Warnings, and Precautions: Risk of hypoglycemia
  40. Adverse Reactions: May cause drowsiness/sedation
  41. Patient Counseling Information: Advises against driving or operating heavy machinery
  42. Indications and Usage: Pain
  43. Indications and Usage: Hypertension
  44. Dosage Form and Strengths: Vaginal product
  45. Indications and Usage: Diabetes
  46. Contraindications, Warnings, and Precautions: Risk of hepatotoxicity
  47. Drug Interactions: Interaction with amiodarone
  48. Drug Interactions: CYP3A4 inducer
  49. Drug Interactions: Interaction with warfarin
  50. Indications and Usage: Asthma/COPD
  51. Contraindications, Warnings, and Precautions: Black Box Warning
  52. Indications and Usage: Anti-infective
  53. Patient Counseling Information: Contains missed dose instructions
  54. Drug Interactions: CYP3A4 inhibitor
  55. How Supplied/Storage and Handling: Store at room temperature
  56. Use in Specific Populations: Not recommended during pregnancy
  57. Adverse Reactions: May cause headache
  58. Dosage Form and Strengths: Oral tablet
  59. Drug Interactions: CYP3A4 substrate
  60. Dosage and Administration: Weekly dosing
  61. Dosage Form and Strengths: Rectal product
  62. Indications and Usage: Depression
  63. Contraindications, Warnings, and Precautions: Risk of C. difficile infection
  64. Dosage Form and Strengths: Injectable medication
  65. Contraindications, Warnings, and Precautions: Risk of severe rash
  66. Dosage Form and Strengths: Ophthalmic product
  67. Use in Specific Populations: Geriatric use described
  68. How Supplied/Storage and Handling: Protect from light
  69. Use in Specific Populations: Not recommended during lactation